Alivus Life Sciences Ltd.

With no major difference for the quarter endedDecember 2022 , the total revenue stood at Rs. 5407.31  millions.Profit for the quarter ended December 2022 grew by 1.23% to Rs. 1049.93 millions from Rs. 1037.13 millions.The company reported a good operating profit of 1520.64 millions compared to 1495.98 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202212	202112	% Var	202212	202112	% Var	202203	202103	% Var
Sales	5407.31	5224.99	3.49	15399.00	16091.57	-4.30	21232.14	18851.65	12.63
Other Income	66.08	35.34	86.98	261.21	96.09	171.84	147.04	8.11	1713.07
PBIDT	1520.64	1495.98	1.65	4619.84	4834.58	-4.44	6307.64	5918.85	6.57
Interest	1.60	0.61	162.30	4.28	278.37	-98.46	279.62	875.47	-68.06
PBDT	1519.04	1495.37	1.58	4615.56	4556.21	1.30	6028.02	5043.38	19.52
Depreciation	107.63	97.39	10.51	305.77	283.23	7.96	378.77	333.94	13.42
PBT	1411.41	1397.98	0.96	4309.79	4272.98	0.86	5649.25	4709.44	19.96
TAX	361.48	360.85	0.17	1103.75	1074.71	2.70	1462.01	1193.63	22.48
Deferred Tax	29.70	41.49	-28.42	70.75	67.49	4.83	85.74	66.17	29.58
PAT	1049.93	1037.13	1.23	3206.04	3198.27	0.24	4187.24	3515.81	19.10
Equity	245.05	245.05	0.00	245.05	245.05	0.00	245.05	19.60	1150.26
PBIDTM(%)	28.12	28.63	-1.78	30.00	30.04	-0.14	29.71	31.40	-5.38